REQUEST A DEMO
Total
USD $0.00
Search more companies

UAB Limedika (Lithuania)

Main Activities: Drugs and Druggists' Sundries Merchant Wholesalers | Other Miscellaneous Nondurable Goods Merchant Wholesalers
Full name: UAB Limedika Profile Updated: January 01, 2025
Buy our report for this company USD 29.95 Most recent financial data: 2024 Available in: English & Russian Download a sample report

UAB Limedika is based in Lithuania. The head office is in Kaunas. The enterprise currently operates in the Drugs and Druggists' Sundries Merchant Wholesalers sector. UAB Limedika was incorporated on April 29, 1994. The total number of employees is currently 324 (2025). From the latest financial highlights, UAB Limedika reported a net sales revenue increase of 12.27% in 2024. The enterprise’s net profit margin increased by 0.11% in 2024.

Headquarters
Karmelavos sen. Ramuciu k. Erdves g. 2
Kaunas; Kaunas County; Postal Code: LT-52114

Contact Details: Purchase the UAB Limedika report to view the information.

Website: http://www.limedika.lt

Basic Information
Total Employees:
Purchase the UAB Limedika report to view the information.
Registered Capital:
Purchase the UAB Limedika report to view the information.
Financial Auditors:
Purchase the UAB Limedika report to view the information.
Incorporation Date:
April 29, 1994
Key Executives
Purchase this report to view the information.
Member of the Management Board
Ownership Details
Purchase this report to view the information.
Company Performance
Financial values in the chart are available after UAB Limedika report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency EUR. Absolute financial data is included in the purchased report.
Net sales revenue
12.27%
Total Operating Revenue
12.27%
Net Profit/Loss for the Period
19.13%
Total Equity
16.07%
Net Profit Margin
0.11%
Return on Equity (ROE)
2.22%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?